The company
Bristol-Myers Squibb Company
BMY · NYSE
BMY stood above a rising 150-day average in 42 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 0.7% below that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 2
- Industry in uptrend
- 31% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $4.6M
- Officials’ trades on record
- 196
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 42 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
196 disclosed lines: House 117, Senate 54, executive 25; 50 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 23 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 12 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 18 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 18 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 11 May 2026filed 1 Jul 2026 |
| Mike Kelly House: U.S. House ClerkPA16 | soldspouse | $15k–$50k | 7 May 2026filed 11 Jun 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 27 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 20 Apr 2026filed 1 Jul 2026 |
| Alan Armstrong Senate: U.S. Senate eFDSenator | bought | $1k–$15k | 27 Mar 2026filed 21 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 18 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 17 Mar 2026filed 14 May 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Cristian MassacesiEVP, Chief Med Offr, Head of Dev | sold | 6,249at $64.57 | 9 Sep 2026filed 10 Sep 2026 |
| Phil M. HolzerSVP and Controller | sold | 500at $67.50 | 25 Aug 2026filed 26 Aug 2026 |
| David V. ElkinsEVP, Chief Financial Officer | sold | 25,519at $61.60 | 1 Apr 2026filed 2 Apr 2026 |
| David V. ElkinsEVP, Chief Financial Officer | sold | 4,481at $62.05 | 1 Apr 2026filed 2 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.